SWOG clinical trial number
SWOG-7407
VP16-213(4'Demethyl-Epipodophyllotoxin-B-D- Ethylidene Glucoside) by Intravenous Infusion on Five Consecutive Days Every Three Weeks in Adults with Hodgkin's Disease and Non-Hodgkin's Lymphomas
Closed
Abbreviated Title
VP16-213(4'Demethyl-Epipodophyllotoxin-B-D- Ethylidene Glucoside) by Intravenous Infusion on Five Consecutive Days Every Three Weeks in Adults with Hodgkin's Disease and Non-Hodgkin's Lymphomas
Activated
05/10/1974
Closed
10/09/1975
Publication Information Expand/Collapse
1978
Evaluation of VP-16-213 in malignant lymphoma and melanoma